Results for tag: "Proleukin"

Proleukin is a type of skin cancer drug used to treat metastatic melanoma and metastatic renal cell carcinoma. It is a recombinant form of interleukin-2, a naturally occurring protein that helps regulate the body's immune system. Proleukin is administered intravenously and works by stimulating the body's own immune system to fight cancer cells. It is used in combination with other treatments such as surgery, radiation, and chemotherapy. Proleukin is a relatively new drug, having been approved by the US Food and Drug Administration in 1998. It is used to treat advanced melanoma and renal cell carcinoma, two of the most common types of skin cancer. It is also used to treat other types of cancer, such as lymphoma and leukemia. Proleukin is available in the market from several companies, including Novartis, Merck, and Bristol-Myers Squibb. It is also available in generic form from several generic drug manufacturers. Show Less Read more